Home/Filings/4/0000921895-22-002200
4//SEC Filing

Funicular Funds, LP 4

Accession 0000921895-22-002200

CIK 0000907654other

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 7:17 PM ET

Size

12.6 KB

Accession

0000921895-22-002200

Insider Transaction Report

Form 4
Period: 2022-07-01
Funicular Funds, LP
10% OwnerOther
Transactions
  • Other

    Put Option

    2022-07-01+14,5001,450,000 total
    Exercise: $2.50From: 2022-12-16Exp: 2022-12-16Common Stock (1,450,000 underlying)
  • Other

    Common Stock

    2022-07-01+2,580,4522,580,452 total
  • Other

    Common Stock

    2022-07-012,580,4522,580,452 total(indirect: By the Funicular Fund, LP)
  • Other

    Put Option

    2022-07-0114,5000 total(indirect: By the Funicular Fund)
    Exercise: $2.50From: 2022-12-16Exp: 2022-12-16Common Stock (1,450,000 underlying)
Footnotes (3)
  • [F1]This Form 4 is filed by Funicular Funds, LP (the "Reporting Person" or the "Fund"). The Reporting Person, the Funicular Fund ("Funicular"), Cable Car Capital LLC ("Cable Car") and Jacob Ma- Weaver may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Person, Funicular and Cable Car and Mr. Ma-Weaver disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
  • [F2]Represents securities directly owned by the Fund. Funicular, as a feeder fund to the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.
  • [F3]The reported transactions involved a transfer of 2,580,452 shares of the Issuer's Common Stock and European-style put options referencing an aggregate of 1,450,000 Shares by Funicular to the Fund in a transaction exempt from Section 16, pursuant to Rule 16a-13 or otherwise.

Issuer

ARCA biopharma, Inc.

CIK 0000907654

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001937147

Filing Metadata

Form type
4
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 7:17 PM ET
Size
12.6 KB